提示：
1、投稿方式：邮箱投稿。
2、期刊网址：https://www.biopharminternational.com/
3、官网邮箱：rpeters@MMHgroup.com
shaigney@MMHgroup.com
4、官网电话：732.596.0276
更多邮箱、电话请查看期刊官网信息。
5、期刊刊期：月刊，一年出版12期。
2021年8月19日星期四
投稿须知【官网信息】
Article/Paper Submission Guidelines
Use these instructions to prepare peer-review papers, technical articles, and other contributions for publication in BioPharm International and on www.BioPharmInternational.com.
Submission Process
Publishing is a deadline-focused business; the editors rely on the cooperation of contributors to meet deadlines and following the editorial review process.
The editorial process is summarized as follows:
• The editors begin work on topics on the editorial calendar approximately four months prior to the month of publication; early contact with the editors via email inquiry is recommended.
• Authors are asked to submit an abstract (250 words) describing the topic and content of the proposed submission, potential figures, expected length and submission date, and a list of authors. The editors review the abstract, offer suggestions, and provide a word count and deadline. Abstracts are due approximately three months prior to the month of publication.
• Final articles, figures, and signed license agreements are due approximately two months prior to publication. Please obtain all necessary legal and company clearances prior to submission.
• The typical word count for a technical article is 1800 to 2000 words, with up to three figures. The word count will be confirmed after review of the abstract.
• Articles are assigned to a lead editor, who will work with the corresponding author through the editing process. Authors will be sent an edited Word document, as well as a layout page proof. Authors must return the edited document and proofs within a few days.
The editors cannot guarantee publication of a submission in a specific issue. All submissions are reviewed and edited for style, content, and length. All peer-review papers are subject to advisory board review. Proofs of edited articles are sent to authors prior to publication.
Originality and Licensing
Originality and Rights
Manuscripts are reviewed with the understanding that they have not been published previously in any format—print or electronic—are not ghostwritten, and are not under consideration for publication elsewhere, including on the Internet.
All articles undergo a thorough check for plagiarism; if plagiarism is found, the article will automatically be rejected, and the author(s) will be banned from publishing in BioPharm International and its sister publications.
Image, Figure, and Table Rights
The author must own the rights to all submitted images, tables, and figures. Graphics from
other sources or third-party sources will not be accepted for publication.
License Agreement
The author and any coauthors are required to sign a license agreement before a manuscript is accepted for publication to provide UBM (a part of Informa plc) permission to publish the original article and its associated figures/tables in print and online.
Editorial Contacts
Submit your article to your corresponding editor or:
Rita Peters, editorial director, rpeters@MMHgroup.com
Susan Haigney, managing editor, shaigney@MMHgroup.com
Prepare Article for Submission
Length
The word count for peer-review papers and technical articles varies between 1000 and 3000 words and may include up to 5 figures and tables. The editors will specify an article length and number of figures for each submission. Manuscripts and figures/tables that exceed the editor’s instructions may not be accepted for consideration or will be edited to fit the available space.
……
更多详情：
https://cdn.sanity.io/files/0vv8moc6/biopharn/a6e2cdf16c85768816bc9aee7790874155e6e681.pdf/BioPharm_Submission_Guidelines_2020.pdf
